InMed: A Text Book Lesson in how Biotechs Drive Share Value Through Innovation.

InMed announces results of a study co-sponsored with the University of British Columbia. The InMed-UBC study is the first ever to report hydrogel-mediated cannabinoid nanoparticle delivery to the eye, resulting in enhanced drug uptake via the cornea and lens. This study further validates the Company’s capacity to conduct a wide spectrum of drug development activities